

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of relaxation of muscle (GO:1901077) | 6.60270255 |
| 2 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.49347157 |
| 3 | striated muscle contraction (GO:0006941) | 5.42693294 |
| 4 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.22572990 |
| 5 | lysine catabolic process (GO:0006554) | 5.21541796 |
| 6 | lysine metabolic process (GO:0006553) | 5.21541796 |
| 7 | regulation of cell communication by electrical coupling (GO:0010649) | 5.19662700 |
| 8 | skeletal muscle contraction (GO:0003009) | 5.05465297 |
| 9 | response to inactivity (GO:0014854) | 4.93974858 |
| 10 | regulation of actin filament-based movement (GO:1903115) | 4.92899987 |
| 11 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.87044743 |
| 12 | glyoxylate metabolic process (GO:0046487) | 4.82257472 |
| 13 | actin filament-based movement (GO:0030048) | 4.82140827 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.79192491 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 4.79192491 |
| 16 | cardiac muscle hypertrophy (GO:0003300) | 4.77926206 |
| 17 | cellular ketone body metabolic process (GO:0046950) | 4.69188472 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.63225177 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 4.63225177 |
| 20 | actomyosin structure organization (GO:0031032) | 4.58990420 |
| 21 | striated muscle hypertrophy (GO:0014897) | 4.53695376 |
| 22 | cardiac muscle cell development (GO:0055013) | 4.44031817 |
| 23 | adult heart development (GO:0007512) | 4.43469221 |
| 24 | * carnitine shuttle (GO:0006853) | 4.35825157 |
| 25 | tricarboxylic acid cycle (GO:0006099) | 4.33135040 |
| 26 | 2-oxoglutarate metabolic process (GO:0006103) | 4.32778659 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 4.26877184 |
| 28 | * fatty acid transmembrane transport (GO:1902001) | 4.25901550 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 4.23726875 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.23593705 |
| 31 | kynurenine metabolic process (GO:0070189) | 4.20838085 |
| 32 | cardiac cell development (GO:0055006) | 4.12238318 |
| 33 | ketone body metabolic process (GO:1902224) | 4.04910636 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 4.00388477 |
| 35 | acetyl-CoA metabolic process (GO:0006084) | 3.98348848 |
| 36 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.94771358 |
| 37 | regulation of sarcomere organization (GO:0060297) | 3.93399735 |
| 38 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.93359904 |
| 39 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.89510785 |
| 40 | muscle contraction (GO:0006936) | 3.89472779 |
| 41 | muscle hypertrophy (GO:0014896) | 3.88668963 |
| 42 | regulation of striated muscle contraction (GO:0006942) | 3.86053029 |
| 43 | sarcomere organization (GO:0045214) | 3.85549680 |
| 44 | tryptophan catabolic process (GO:0006569) | 3.85422752 |
| 45 | indole-containing compound catabolic process (GO:0042436) | 3.85422752 |
| 46 | indolalkylamine catabolic process (GO:0046218) | 3.85422752 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.85060530 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 3.85001293 |
| 49 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.82762857 |
| 50 | response to muscle activity (GO:0014850) | 3.82660595 |
| 51 | cysteine metabolic process (GO:0006534) | 3.82027259 |
| 52 | muscle tissue morphogenesis (GO:0060415) | 3.80784196 |
| 53 | fatty acid beta-oxidation (GO:0006635) | 3.75977772 |
| 54 | relaxation of cardiac muscle (GO:0055119) | 3.74012291 |
| 55 | bile acid biosynthetic process (GO:0006699) | 3.72726866 |
| 56 | short-chain fatty acid metabolic process (GO:0046459) | 3.71446682 |
| 57 | actin-myosin filament sliding (GO:0033275) | 3.70057165 |
| 58 | muscle filament sliding (GO:0030049) | 3.70057165 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 3.69281571 |
| 60 | muscle fiber development (GO:0048747) | 3.68869290 |
| 61 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65029675 |
| 62 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.64992387 |
| 63 | succinate metabolic process (GO:0006105) | 3.59690127 |
| 64 | tryptophan metabolic process (GO:0006568) | 3.58427890 |
| 65 | response to caffeine (GO:0031000) | 3.56745003 |
| 66 | regulation of membrane repolarization (GO:0060306) | 3.56715728 |
| 67 | fatty acid oxidation (GO:0019395) | 3.55015619 |
| 68 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.54721592 |
| 69 | muscle system process (GO:0003012) | 3.52208032 |
| 70 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.50656507 |
| 71 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.50570832 |
| 72 | regulation of the force of heart contraction (GO:0002026) | 3.50012969 |
| 73 | homocysteine metabolic process (GO:0050667) | 3.49974912 |
| 74 | lipid oxidation (GO:0034440) | 3.47871812 |
| 75 | serine family amino acid catabolic process (GO:0009071) | 3.47155978 |
| 76 | creatine metabolic process (GO:0006600) | 3.46833512 |
| 77 | cardiac myofibril assembly (GO:0055003) | 3.46512376 |
| 78 | fatty acid catabolic process (GO:0009062) | 3.43996448 |
| 79 | myotube cell development (GO:0014904) | 3.42079372 |
| 80 | alpha-amino acid catabolic process (GO:1901606) | 3.41998693 |
| 81 | * amino-acid betaine transport (GO:0015838) | 3.39215078 |
| 82 | * carnitine transport (GO:0015879) | 3.39215078 |
| 83 | glutamate metabolic process (GO:0006536) | 3.38668903 |
| 84 | striated muscle cell development (GO:0055002) | 3.37274813 |
| 85 | cellular glucuronidation (GO:0052695) | 3.36333294 |
| 86 | urea cycle (GO:0000050) | 3.34871438 |
| 87 | urea metabolic process (GO:0019627) | 3.34871438 |
| 88 | cardiac muscle cell action potential (GO:0086001) | 3.34443160 |
| 89 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.32199039 |
| 90 | monocarboxylic acid catabolic process (GO:0072329) | 3.31740448 |
| 91 | * carnitine transmembrane transport (GO:1902603) | 3.31506354 |
| 92 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.31180437 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 3.30396328 |
| 94 | regulation of skeletal muscle contraction (GO:0014819) | 3.30235059 |
| 95 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.29955349 |
| 96 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.29473761 |
| 97 | myofibril assembly (GO:0030239) | 3.29101436 |
| 98 | cell communication by electrical coupling (GO:0010644) | 3.28924122 |
| 99 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.26610863 |
| 100 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.26610863 |
| 101 | cardiac muscle adaptation (GO:0014887) | 3.26045658 |
| 102 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.26045658 |
| 103 | muscle hypertrophy in response to stress (GO:0003299) | 3.26045658 |
| 104 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.24866544 |
| 105 | branched-chain amino acid catabolic process (GO:0009083) | 3.24199253 |
| 106 | drug transmembrane transport (GO:0006855) | 3.23139206 |
| 107 | drug catabolic process (GO:0042737) | 3.22766931 |
| 108 | coenzyme catabolic process (GO:0009109) | 3.22007040 |
| 109 | negative regulation of sterol transport (GO:0032372) | 3.21980118 |
| 110 | negative regulation of cholesterol transport (GO:0032375) | 3.21980118 |
| 111 | flavonoid metabolic process (GO:0009812) | 3.20216666 |
| 112 | skeletal muscle fiber development (GO:0048741) | 3.19823321 |
| 113 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.19801973 |
| 114 | glycogen catabolic process (GO:0005980) | 3.18319246 |
| 115 | carnitine metabolic process (GO:0009437) | 3.17418991 |
| 116 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.17346087 |
| 117 | NADH metabolic process (GO:0006734) | 3.17060649 |
| 118 | relaxation of muscle (GO:0090075) | 3.16853582 |
| 119 | bile acid metabolic process (GO:0008206) | 3.16813681 |
| 120 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.16300276 |
| 121 | muscle cell cellular homeostasis (GO:0046716) | 3.15309733 |
| 122 | tricarboxylic acid metabolic process (GO:0072350) | 3.13058513 |
| 123 | regulation of triglyceride catabolic process (GO:0010896) | 3.12968737 |
| 124 | ethanol oxidation (GO:0006069) | 3.12774963 |
| 125 | striated muscle adaptation (GO:0014888) | 3.12428604 |
| 126 | otic vesicle formation (GO:0030916) | 3.11321414 |
| 127 | actin-mediated cell contraction (GO:0070252) | 3.10943142 |
| 128 | response to mercury ion (GO:0046689) | 3.09975158 |
| 129 | oxaloacetate metabolic process (GO:0006107) | 3.09895200 |
| 130 | organic acid catabolic process (GO:0016054) | 3.09490572 |
| 131 | carboxylic acid catabolic process (GO:0046395) | 3.09490572 |
| 132 | cellular modified amino acid catabolic process (GO:0042219) | 3.08692322 |
| 133 | cardiac muscle contraction (GO:0060048) | 3.08644028 |
| 134 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.08400624 |
| 135 | valine metabolic process (GO:0006573) | 3.07939037 |
| 136 | glucan catabolic process (GO:0009251) | 3.07838602 |
| 137 | branched-chain amino acid metabolic process (GO:0009081) | 3.07672364 |
| 138 | complement activation, alternative pathway (GO:0006957) | 3.06719695 |
| 139 | regulation of heart rate (GO:0002027) | 3.06666896 |
| 140 | aromatic amino acid family metabolic process (GO:0009072) | 3.05707415 |
| 141 | nitrogen cycle metabolic process (GO:0071941) | 3.05698545 |
| 142 | plasma membrane repair (GO:0001778) | 3.05421312 |
| 143 | regulation of protein activation cascade (GO:2000257) | 3.05392879 |
| 144 | regulation of fatty acid oxidation (GO:0046320) | 3.02879394 |
| 145 | regulation of cardiac muscle contraction (GO:0055117) | 3.02359053 |
| 146 | regulation of cofactor metabolic process (GO:0051193) | 3.01436258 |
| 147 | regulation of coenzyme metabolic process (GO:0051196) | 3.01436258 |
| 148 | phospholipid homeostasis (GO:0055091) | 3.01162070 |
| 149 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.01129902 |
| 150 | * quaternary ammonium group transport (GO:0015697) | 2.98842326 |
| 151 | positive regulation of cation channel activity (GO:2001259) | 2.98495748 |
| 152 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.97940315 |
| 153 | cell communication involved in cardiac conduction (GO:0086065) | 2.97639780 |
| 154 | uronic acid metabolic process (GO:0006063) | 2.97271975 |
| 155 | glucuronate metabolic process (GO:0019585) | 2.97271975 |
| 156 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.97009225 |
| 157 | skeletal muscle adaptation (GO:0043501) | 2.93554846 |
| 158 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.87759235 |
| 159 | muscle cell development (GO:0055001) | 2.87112499 |
| 160 | positive regulation of sodium ion transport (GO:0010765) | 2.85652060 |
| 161 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.84250227 |
| 162 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.84024221 |
| 163 | cardiac chamber formation (GO:0003207) | 2.78353564 |
| 164 | detection of calcium ion (GO:0005513) | 2.78143696 |
| 165 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.73164238 |
| 166 | skeletal muscle tissue development (GO:0007519) | 2.72616526 |
| 167 | cardiac ventricle formation (GO:0003211) | 2.71064123 |
| 168 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.69911390 |
| 169 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.69911390 |
| 170 | regulation of ATP catabolic process (GO:1903289) | 2.66231062 |
| 171 | regulation of ATPase activity (GO:0043462) | 2.66231062 |
| 172 | heart contraction (GO:0060047) | 2.65620969 |
| 173 | heart process (GO:0003015) | 2.65620969 |
| 174 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.63338195 |
| 175 | regulation of cation channel activity (GO:2001257) | 2.62808599 |
| 176 | regulation of muscle system process (GO:0090257) | 2.60201506 |
| 177 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.59760250 |
| 178 | myotube differentiation (GO:0014902) | 2.56864751 |
| 179 | negative regulation of protein localization to cell surface (GO:2000009) | 2.55344469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.00396735 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04479906 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.94265586 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.34970985 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.12762060 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.40896715 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.14066349 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.01912613 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.85234433 |
| 10 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.68737389 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.55457828 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.52153547 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.42074036 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.37684639 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.25636356 |
| 16 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.22893125 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.13069886 |
| 18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.09684530 |
| 19 | * FUS_26573619_Chip-Seq_HEK293_Human | 2.05826991 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.01421075 |
| 21 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.94361787 |
| 22 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.93639843 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.91819670 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.90471659 |
| 25 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85228072 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.81162203 |
| 27 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75330556 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.69301277 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65025210 |
| 30 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.63234597 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62141350 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59310371 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56985338 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47017464 |
| 35 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.45692233 |
| 36 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45247380 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.43068972 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42284259 |
| 39 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40906153 |
| 40 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40706352 |
| 41 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40706352 |
| 42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40338621 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.40253955 |
| 44 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.39669646 |
| 45 | TCF4_23295773_ChIP-Seq_U87_Human | 1.38904446 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.37951866 |
| 47 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.36699075 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35633504 |
| 49 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.35055069 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34848352 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34845376 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33136595 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32090141 |
| 54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31915693 |
| 55 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.31050407 |
| 56 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.26252628 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24167402 |
| 58 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23874977 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23604766 |
| 60 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23222798 |
| 61 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22159705 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21915062 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21494952 |
| 64 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21493004 |
| 65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21493004 |
| 66 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21355544 |
| 67 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.17228072 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17139009 |
| 69 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16487478 |
| 70 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15528997 |
| 71 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13407154 |
| 72 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12036412 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12032379 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11204399 |
| 75 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10321316 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09872051 |
| 77 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.09655367 |
| 78 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09495652 |
| 79 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08678040 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07511273 |
| 81 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07511273 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07269201 |
| 83 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07188335 |
| 84 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.05785625 |
| 85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05624934 |
| 86 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05141192 |
| 87 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04586724 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04259441 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04259441 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03877198 |
| 91 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03615729 |
| 92 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03489217 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01710292 |
| 94 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.01523532 |
| 95 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.01085202 |
| 96 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00495660 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00389885 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99666656 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99415658 |
| 100 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99207751 |
| 101 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99092363 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99023038 |
| 103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98999348 |
| 104 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.98920313 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98845479 |
| 106 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98565220 |
| 107 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98157859 |
| 108 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98157859 |
| 109 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98155176 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97705833 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96694234 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93164194 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93086916 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92095012 |
| 115 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89779388 |
| 116 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89505122 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87984506 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87915474 |
| 119 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87904099 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87758830 |
| 121 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87401946 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87319179 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86838160 |
| 124 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.85902828 |
| 125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84863891 |
| 126 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84835448 |
| 127 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.84047700 |
| 128 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.82641293 |
| 129 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81478906 |
| 130 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.80734940 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78809449 |
| 132 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.78537558 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77787410 |
| 134 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.77268850 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76718266 |
| 136 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.76314265 |
| 137 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.75288354 |
| 138 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.74586288 |
| 139 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73745847 |
| 140 | AR_25329375_ChIP-Seq_VCAP_Human | 0.73116422 |
| 141 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.72596875 |
| 142 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.72502857 |
| 143 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.71712422 |
| 144 | AR_19668381_ChIP-Seq_PC3_Human | 0.71682658 |
| 145 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70760137 |
| 146 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.70069853 |
| 147 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.70069853 |
| 148 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.70003678 |
| 149 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.69650046 |
| 150 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.69552898 |
| 151 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68771890 |
| 152 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68373722 |
| 153 | RXR_22108803_ChIP-Seq_LS180_Human | 0.68171533 |
| 154 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.68165218 |
| 155 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.67999867 |
| 156 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.66572956 |
| 157 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.66366664 |
| 158 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.66207704 |
| 159 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65827752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.31734909 |
| 2 | MP0005360_urolithiasis | 5.14128893 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.38792582 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.03144723 |
| 5 | MP0005365_abnormal_bile_salt | 3.90476173 |
| 6 | MP0003646_muscle_fatigue | 3.68340160 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.15465658 |
| 8 | MP0000751_myopathy | 3.09215348 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.92718648 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.79747937 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.78135200 |
| 12 | MP0000749_muscle_degeneration | 2.65363085 |
| 13 | MP0003252_abnormal_bile_duct | 2.64092315 |
| 14 | MP0004215_abnormal_myocardial_fiber | 2.59131546 |
| 15 | * MP0004130_abnormal_muscle_cell | 2.36520979 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.29377999 |
| 17 | MP0005332_abnormal_amino_acid | 2.26709355 |
| 18 | MP0005330_cardiomyopathy | 2.23589044 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.14781651 |
| 20 | MP0003195_calcinosis | 2.13441999 |
| 21 | MP0005083_abnormal_biliary_tract | 2.00091661 |
| 22 | MP0005620_abnormal_muscle_contractility | 1.96581938 |
| 23 | MP0004087_abnormal_muscle_fiber | 1.96363820 |
| 24 | MP0002269_muscular_atrophy | 1.93772984 |
| 25 | MP0002972_abnormal_cardiac_muscle | 1.86639272 |
| 26 | MP0000747_muscle_weakness | 1.80528785 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.73906617 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.71852383 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.70451385 |
| 30 | MP0004484_altered_response_of | 1.65965919 |
| 31 | MP0004043_abnormal_pH_regulation | 1.65193643 |
| 32 | MP0002106_abnormal_muscle_physiology | 1.65009751 |
| 33 | * MP0002118_abnormal_lipid_homeostasis | 1.55304686 |
| 34 | MP0003137_abnormal_impulse_conducting | 1.51878780 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.51853913 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.48309684 |
| 37 | MP0001661_extended_life_span | 1.43226585 |
| 38 | MP0009840_abnormal_foam_cell | 1.42187913 |
| 39 | MP0001544_abnormal_cardiovascular_syste | 1.39393451 |
| 40 | MP0005385_cardiovascular_system_phenoty | 1.39393451 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.39338867 |
| 42 | MP0005451_abnormal_body_composition | 1.37402167 |
| 43 | MP0005369_muscle_phenotype | 1.31306174 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.31223496 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30868483 |
| 46 | MP0006138_congestive_heart_failure | 1.30080770 |
| 47 | MP0010630_abnormal_cardiac_muscle | 1.29566488 |
| 48 | MP0004233_abnormal_muscle_weight | 1.29521676 |
| 49 | MP0000759_abnormal_skeletal_muscle | 1.29061725 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.23704707 |
| 51 | MP0000750_abnormal_muscle_regeneration | 1.22906781 |
| 52 | MP0004085_abnormal_heartbeat | 1.22903765 |
| 53 | MP0005423_abnormal_somatic_nervous | 1.22824003 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22014726 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.20862802 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 1.20684641 |
| 57 | MP0000733_abnormal_muscle_development | 1.18927014 |
| 58 | MP0000609_abnormal_liver_physiology | 1.17510277 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.16798752 |
| 60 | MP0003880_abnormal_central_pattern | 1.13396356 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.12330971 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.10247832 |
| 63 | MP0001984_abnormal_olfaction | 1.09596085 |
| 64 | MP0003868_abnormal_feces_composition | 1.08797271 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.08623035 |
| 66 | * MP0009643_abnormal_urine_homeostasis | 1.07341918 |
| 67 | MP0002332_abnormal_exercise_endurance | 1.05126237 |
| 68 | MP0003136_yellow_coat_color | 1.04363348 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.03397343 |
| 70 | MP0010030_abnormal_orbit_morphology | 1.02261983 |
| 71 | MP0004270_analgesia | 0.98805469 |
| 72 | MP0002822_catalepsy | 0.97322154 |
| 73 | MP0002234_abnormal_pharynx_morphology | 0.96897273 |
| 74 | MP0005535_abnormal_body_temperature | 0.93772391 |
| 75 | MP0000230_abnormal_systemic_arterial | 0.90655842 |
| 76 | * MP0002078_abnormal_glucose_homeostasis | 0.89987887 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.88868948 |
| 78 | MP0002971_abnormal_brown_adipose | 0.88626926 |
| 79 | MP0005670_abnormal_white_adipose | 0.88308297 |
| 80 | * MP0005266_abnormal_metabolism | 0.85952430 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 0.85756362 |
| 82 | MP0002734_abnormal_mechanical_nocicepti | 0.85622724 |
| 83 | MP0003329_amyloid_beta_deposits | 0.84472167 |
| 84 | MP0005187_abnormal_penis_morphology | 0.81927604 |
| 85 | MP0002127_abnormal_cardiovascular_syste | 0.80745853 |
| 86 | MP0001529_abnormal_vocalization | 0.79977820 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.78656264 |
| 88 | MP0001764_abnormal_homeostasis | 0.77968201 |
| 89 | MP0001756_abnormal_urination | 0.75759492 |
| 90 | MP0000579_abnormal_nail_morphology | 0.75747055 |
| 91 | MP0000266_abnormal_heart_morphology | 0.74071508 |
| 92 | MP0004142_abnormal_muscle_tone | 0.73506509 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.72639794 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.72630037 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.72448374 |
| 96 | MP0001486_abnormal_startle_reflex | 0.72215081 |
| 97 | MP0003937_abnormal_limbs/digits/tail_de | 0.71514479 |
| 98 | MP0001346_abnormal_lacrimal_gland | 0.69791512 |
| 99 | MP0004859_abnormal_synaptic_plasticity | 0.68543295 |
| 100 | MP0005334_abnormal_fat_pad | 0.68470615 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.68203121 |
| 102 | MP0005551_abnormal_eye_electrophysiolog | 0.67322740 |
| 103 | MP0002938_white_spotting | 0.67012893 |
| 104 | MP0003890_abnormal_embryonic-extraembry | 0.66715299 |
| 105 | MP0000372_irregular_coat_pigmentation | 0.65108778 |
| 106 | MP0005253_abnormal_eye_physiology | 0.63170987 |
| 107 | MP0002272_abnormal_nervous_system | 0.62606357 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.60813730 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.60395298 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.60213236 |
| 111 | MP0004510_myositis | 0.59844281 |
| 112 | MP0009046_muscle_twitch | 0.59425385 |
| 113 | MP0003122_maternal_imprinting | 0.58922689 |
| 114 | MP0003045_fibrosis | 0.58479077 |
| 115 | MP0003755_abnormal_palate_morphology | 0.58402005 |
| 116 | MP0003567_abnormal_fetal_cardiomyocyte | 0.58341875 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.57812784 |
| 118 | * MP0009745_abnormal_behavioral_response | 0.57595923 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.57363678 |
| 120 | MP0010368_abnormal_lymphatic_system | 0.57330282 |
| 121 | MP0000631_abnormal_neuroendocrine_gland | 0.57281292 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.57038420 |
| 123 | MP0002233_abnormal_nose_morphology | 0.55790847 |
| 124 | MP0000003_abnormal_adipose_tissue | 0.55588342 |
| 125 | MP0009250_abnormal_appendicular_skeleto | 0.54681153 |
| 126 | MP0002108_abnormal_muscle_morphology | 0.54662272 |
| 127 | * MP0009642_abnormal_blood_homeostasis | 0.53641841 |
| 128 | MP0000778_abnormal_nervous_system | 0.53233694 |
| 129 | MP0000604_amyloidosis | 0.53011518 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.52759915 |
| 131 | * MP0005376_homeostasis/metabolism_phenot | 0.52479127 |
| 132 | MP0000566_synostosis | 0.52049795 |
| 133 | MP0005165_increased_susceptibility_to | 0.51357748 |
| 134 | MP0004147_increased_porphyrin_level | 0.50562338 |
| 135 | MP0004924_abnormal_behavior | 0.50243525 |
| 136 | MP0005386_behavior/neurological_phenoty | 0.50243525 |
| 137 | MP0000534_abnormal_ureter_morphology | 0.50016359 |
| 138 | MP0002064_seizures | 0.49439793 |
| 139 | MP0005646_abnormal_pituitary_gland | 0.48754993 |
| 140 | MP0000598_abnormal_liver_morphology | 0.48437608 |
| 141 | MP0004133_heterotaxia | 0.48342982 |
| 142 | MP0001485_abnormal_pinna_reflex | 0.48137556 |
| 143 | MP0002067_abnormal_sensory_capabilities | 0.48030073 |
| 144 | MP0003828_pulmonary_edema | 0.46842719 |
| 145 | MP0001293_anophthalmia | 0.46615895 |
| 146 | MP0003942_abnormal_urinary_system | 0.46507931 |
| 147 | MP0002128_abnormal_blood_circulation | 0.46439603 |
| 148 | * MP0003953_abnormal_hormone_level | 0.46319520 |
| 149 | * MP0005448_abnormal_energy_balance | 0.45901877 |
| 150 | MP0003635_abnormal_synaptic_transmissio | 0.45896172 |
| 151 | MP0002735_abnormal_chemical_nociception | 0.45852308 |
| 152 | MP0009672_abnormal_birth_weight | 0.45493971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.00947929 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.78489668 |
| 3 | Sudden death (HP:0001699) | 4.57687269 |
| 4 | Rimmed vacuoles (HP:0003805) | 4.33185737 |
| 5 | Myoglobinuria (HP:0002913) | 4.23905544 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.03483120 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.00085372 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.94957306 |
| 9 | Ketosis (HP:0001946) | 3.87980519 |
| 10 | Ketoacidosis (HP:0001993) | 3.81107445 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.76084259 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.65819058 |
| 13 | Myopathic facies (HP:0002058) | 3.65698070 |
| 14 | Hyperammonemia (HP:0001987) | 3.60836847 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.59833134 |
| 16 | Neck muscle weakness (HP:0000467) | 3.53441120 |
| 17 | Gout (HP:0001997) | 3.50087438 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.47827682 |
| 19 | Hyperglycinuria (HP:0003108) | 3.44768087 |
| 20 | Xanthomatosis (HP:0000991) | 3.42242476 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 3.35943429 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.25578965 |
| 23 | Ventricular tachycardia (HP:0004756) | 3.23891420 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 3.23491890 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17282580 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.17282580 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.17193796 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.15781516 |
| 29 | Hypobetalipoproteinemia (HP:0003563) | 3.15610852 |
| 30 | Abnormality of the calf musculature (HP:0001430) | 3.13453542 |
| 31 | Hyperglycinemia (HP:0002154) | 3.12928464 |
| 32 | Muscle fiber inclusion bodies (HP:0100299) | 3.03076835 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 3.02666718 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.01403430 |
| 35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.94153606 |
| 36 | Dicarboxylic aciduria (HP:0003215) | 2.94153606 |
| 37 | Syncope (HP:0001279) | 2.93722704 |
| 38 | Frequent falls (HP:0002359) | 2.92987516 |
| 39 | Hypolipoproteinemia (HP:0010981) | 2.92690069 |
| 40 | Calcaneovalgus deformity (HP:0001848) | 2.92480790 |
| 41 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.91631723 |
| 42 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.90535492 |
| 43 | Absent phalangeal crease (HP:0006109) | 2.89535868 |
| 44 | Ulnar deviation of the wrist (HP:0003049) | 2.89485137 |
| 45 | Round ear (HP:0100830) | 2.88500522 |
| 46 | Fetal akinesia sequence (HP:0001989) | 2.87454621 |
| 47 | EMG: myopathic abnormalities (HP:0003458) | 2.81678746 |
| 48 | Hyperlipoproteinemia (HP:0010980) | 2.81573084 |
| 49 | Cerebral edema (HP:0002181) | 2.78278597 |
| 50 | Areflexia of lower limbs (HP:0002522) | 2.78027135 |
| 51 | Palpitations (HP:0001962) | 2.77651656 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.76812813 |
| 53 | EMG: neuropathic changes (HP:0003445) | 2.67083625 |
| 54 | Hyperuricemia (HP:0002149) | 2.66857655 |
| 55 | Increased purine levels (HP:0004368) | 2.66857655 |
| 56 | Generalized muscle weakness (HP:0003324) | 2.66317089 |
| 57 | Epidermoid cyst (HP:0200040) | 2.65944276 |
| 58 | Atrial fibrillation (HP:0005110) | 2.65634261 |
| 59 | Prolonged partial thromboplastin time (HP:0003645) | 2.63879374 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.63699802 |
| 61 | Subaortic stenosis (HP:0001682) | 2.60484841 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.60484841 |
| 63 | Asymmetric septal hypertrophy (HP:0001670) | 2.60134618 |
| 64 | Metabolic acidosis (HP:0001942) | 2.59264657 |
| 65 | Muscle stiffness (HP:0003552) | 2.58666184 |
| 66 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.58485829 |
| 67 | Complement deficiency (HP:0004431) | 2.58232230 |
| 68 | Hip contracture (HP:0003273) | 2.57685750 |
| 69 | Deformed tarsal bones (HP:0008119) | 2.56861026 |
| 70 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.53541005 |
| 71 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.53105266 |
| 72 | Difficulty running (HP:0009046) | 2.51631297 |
| 73 | Nemaline bodies (HP:0003798) | 2.49620898 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.49498276 |
| 75 | Ventricular arrhythmia (HP:0004308) | 2.48814678 |
| 76 | Lipoatrophy (HP:0100578) | 2.48153924 |
| 77 | Primary atrial arrhythmia (HP:0001692) | 2.47343874 |
| 78 | Myotonia (HP:0002486) | 2.46556334 |
| 79 | Abnormal finger flexion creases (HP:0006143) | 2.44051769 |
| 80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.40170131 |
| 81 | Lethargy (HP:0001254) | 2.39029735 |
| 82 | Cholelithiasis (HP:0001081) | 2.34082239 |
| 83 | Abnormal atrioventricular conduction (HP:0005150) | 2.33254145 |
| 84 | Proximal tubulopathy (HP:0000114) | 2.33208397 |
| 85 | Bundle branch block (HP:0011710) | 2.33052049 |
| 86 | Supraventricular tachycardia (HP:0004755) | 2.32692936 |
| 87 | Hyperventilation (HP:0002883) | 2.32402107 |
| 88 | Gowers sign (HP:0003391) | 2.32111207 |
| 89 | Limb-girdle muscle atrophy (HP:0003797) | 2.28111556 |
| 90 | Supraventricular arrhythmia (HP:0005115) | 2.27637648 |
| 91 | Scapular winging (HP:0003691) | 2.27551855 |
| 92 | Dilated cardiomyopathy (HP:0001644) | 2.26390557 |
| 93 | Muscular dystrophy (HP:0003560) | 2.26097093 |
| 94 | Proximal amyotrophy (HP:0007126) | 2.25796050 |
| 95 | Hyperkalemia (HP:0002153) | 2.24529114 |
| 96 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24524648 |
| 97 | Acute encephalopathy (HP:0006846) | 2.24182960 |
| 98 | Prolonged QT interval (HP:0001657) | 2.22914634 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 2.22575820 |
| 100 | Abnormality of serum amino acid levels (HP:0003112) | 2.22540147 |
| 101 | Left ventricular hypertrophy (HP:0001712) | 2.22085625 |
| 102 | Generalized aminoaciduria (HP:0002909) | 2.19025985 |
| 103 | Increased variability in muscle fiber diameter (HP:0003557) | 2.17980295 |
| 104 | Increased connective tissue (HP:0009025) | 2.17505531 |
| 105 | Limited hip movement (HP:0008800) | 2.15506139 |
| 106 | Skin nodule (HP:0200036) | 2.15165959 |
| 107 | Fat malabsorption (HP:0002630) | 2.14881139 |
| 108 | Heart block (HP:0012722) | 2.11937300 |
| 109 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11836294 |
| 110 | Atrioventricular block (HP:0001678) | 2.11653854 |
| 111 | Delayed CNS myelination (HP:0002188) | 2.11294465 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.10691449 |
| 113 | Hyperglycemia (HP:0003074) | 2.09767927 |
| 114 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.08915924 |
| 115 | Ventricular fibrillation (HP:0001663) | 2.07101734 |
| 116 | Ragged-red muscle fibers (HP:0003200) | 2.04448909 |
| 117 | Malignant hyperthermia (HP:0002047) | 2.03869862 |
| 118 | Vomiting (HP:0002013) | 2.02216330 |
| 119 | Pheochromocytoma (HP:0002666) | 2.00766041 |
| 120 | Abnormality of methionine metabolism (HP:0010901) | 2.00741845 |
| 121 | Late onset (HP:0003584) | 2.00095384 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 1.99614852 |
| 123 | Cholecystitis (HP:0001082) | 1.99614852 |
| 124 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96927409 |
| 125 | Hepatic necrosis (HP:0002605) | 1.95079979 |
| 126 | Distal arthrogryposis (HP:0005684) | 1.94980892 |
| 127 | Conjunctival hamartoma (HP:0100780) | 1.94778648 |
| 128 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.94555867 |
| 129 | Neonatal onset (HP:0003623) | 1.93560447 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 1.92473949 |
| 131 | Glycosuria (HP:0003076) | 1.92473949 |
| 132 | Abnormality of the foot musculature (HP:0001436) | 1.92373907 |
| 133 | Waddling gait (HP:0002515) | 1.84950476 |
| 134 | Long clavicles (HP:0000890) | 1.74857902 |
| 135 | Aplasia of the musculature (HP:0100854) | 1.69327339 |
| 136 | Diaphragmatic weakness (HP:0009113) | 1.68076100 |
| 137 | Steppage gait (HP:0003376) | 1.67704721 |
| 138 | Foot dorsiflexor weakness (HP:0009027) | 1.65907512 |
| 139 | Broad-based gait (HP:0002136) | 1.63289670 |
| 140 | Weak cry (HP:0001612) | 1.63010623 |
| 141 | Fatigable weakness (HP:0003473) | 1.59524453 |
| 142 | Abnormality of the neuromuscular junction (HP:0003398) | 1.59524453 |
| 143 | Abnormality of the calcaneus (HP:0008364) | 1.58794712 |
| 144 | Nonprogressive disorder (HP:0003680) | 1.55988869 |
| 145 | Progressive muscle weakness (HP:0003323) | 1.54733010 |
| 146 | Bulbar palsy (HP:0001283) | 1.51107934 |
| 147 | Exercise intolerance (HP:0003546) | 1.49501905 |
| 148 | Increased serum pyruvate (HP:0003542) | 1.47664569 |
| 149 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.46991593 |
| 150 | Abnormality of the ischium (HP:0003174) | 1.46398702 |
| 151 | Abnormality of potassium homeostasis (HP:0011042) | 1.42825125 |
| 152 | Abnormal EKG (HP:0003115) | 1.40125840 |
| 153 | Abnormality of glycolysis (HP:0004366) | 1.36121325 |
| 154 | Difficulty climbing stairs (HP:0003551) | 1.35689013 |
| 155 | Metatarsus adductus (HP:0001840) | 1.34266944 |
| 156 | Distal lower limb amyotrophy (HP:0008944) | 1.33761240 |
| 157 | Toxemia of pregnancy (HP:0100603) | 1.33392671 |
| 158 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.33238801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.52516677 |
| 2 | PHKG1 | 3.67264309 |
| 3 | PHKG2 | 3.67264309 |
| 4 | BCKDK | 3.44766001 |
| 5 | PDK3 | 3.02486147 |
| 6 | PDK4 | 3.02486147 |
| 7 | TTN | 2.98881182 |
| 8 | PKN2 | 2.45829356 |
| 9 | NEK1 | 2.43210646 |
| 10 | MAP2K4 | 2.11353460 |
| 11 | LMTK2 | 2.03652720 |
| 12 | WNK4 | 1.96560939 |
| 13 | MYLK | 1.92686534 |
| 14 | TRIB3 | 1.90625621 |
| 15 | PINK1 | 1.87164359 |
| 16 | PDK2 | 1.70739114 |
| 17 | PIK3CA | 1.67882491 |
| 18 | INSRR | 1.63777521 |
| 19 | SIK1 | 1.62650006 |
| 20 | TNIK | 1.61363388 |
| 21 | STK24 | 1.59538421 |
| 22 | DMPK | 1.48340008 |
| 23 | MAP3K4 | 1.46096677 |
| 24 | MARK1 | 1.45189270 |
| 25 | MST1R | 1.37784812 |
| 26 | FRK | 1.33528755 |
| 27 | MAPK12 | 1.26784394 |
| 28 | NME1 | 1.23494942 |
| 29 | DAPK2 | 1.22044447 |
| 30 | PIK3CG | 1.19267520 |
| 31 | MAP3K9 | 1.16474426 |
| 32 | STK38L | 1.16212061 |
| 33 | WNK3 | 1.16207243 |
| 34 | ERBB3 | 1.11510017 |
| 35 | PNCK | 1.08796257 |
| 36 | CAMK1D | 1.08248262 |
| 37 | PAK3 | 1.03443042 |
| 38 | OXSR1 | 1.03318302 |
| 39 | LATS2 | 1.03233958 |
| 40 | LATS1 | 1.03056482 |
| 41 | STK39 | 1.00340688 |
| 42 | * PRKAA1 | 0.99422552 |
| 43 | BMPR1B | 0.99211524 |
| 44 | TIE1 | 0.98390263 |
| 45 | RIPK1 | 0.98323866 |
| 46 | EPHA4 | 0.97369282 |
| 47 | CAMK1G | 0.96922887 |
| 48 | TRPM7 | 0.94147068 |
| 49 | FGFR4 | 0.92500072 |
| 50 | ERBB4 | 0.92376356 |
| 51 | STK38 | 0.89375377 |
| 52 | KSR2 | 0.88725865 |
| 53 | * MAP3K7 | 0.85886855 |
| 54 | MAP4K2 | 0.84537710 |
| 55 | PTK6 | 0.81211105 |
| 56 | LIMK1 | 0.79258061 |
| 57 | * PRKAA2 | 0.77491855 |
| 58 | MAPK13 | 0.75809196 |
| 59 | MAPK11 | 0.74668192 |
| 60 | MUSK | 0.74630497 |
| 61 | STK3 | 0.73463340 |
| 62 | CAMK2D | 0.73368227 |
| 63 | CAMKK1 | 0.72682318 |
| 64 | CAMK2G | 0.72314464 |
| 65 | SGK3 | 0.71949705 |
| 66 | PAK6 | 0.71607017 |
| 67 | SGK223 | 0.71176317 |
| 68 | SGK494 | 0.71176317 |
| 69 | EPHA3 | 0.69152181 |
| 70 | CAMKK2 | 0.67841127 |
| 71 | CAMK4 | 0.66729101 |
| 72 | MAP2K7 | 0.65972269 |
| 73 | CAMK2A | 0.65563977 |
| 74 | SGK2 | 0.64715855 |
| 75 | MINK1 | 0.64451385 |
| 76 | MAP2K6 | 0.62729995 |
| 77 | RET | 0.62227451 |
| 78 | CCNB1 | 0.62218607 |
| 79 | NTRK3 | 0.61126002 |
| 80 | PRKG1 | 0.59892495 |
| 81 | PDPK1 | 0.57255194 |
| 82 | EEF2K | 0.56865445 |
| 83 | MAP3K5 | 0.56291773 |
| 84 | MAPKAPK3 | 0.55981639 |
| 85 | FLT3 | 0.55366437 |
| 86 | ROCK1 | 0.55328733 |
| 87 | CAMK2B | 0.54742483 |
| 88 | MAP2K3 | 0.54718837 |
| 89 | PRKCE | 0.54342416 |
| 90 | PRKD1 | 0.53900137 |
| 91 | NLK | 0.53748484 |
| 92 | GRK7 | 0.53645953 |
| 93 | AKT2 | 0.53342809 |
| 94 | DAPK3 | 0.52266258 |
| 95 | * PRKACG | 0.50863327 |
| 96 | PDK1 | 0.50582941 |
| 97 | CAMK1 | 0.50443496 |
| 98 | BRSK2 | 0.50387111 |
| 99 | PKN1 | 0.50203665 |
| 100 | MAP2K1 | 0.46726230 |
| 101 | MET | 0.46347340 |
| 102 | ILK | 0.44890496 |
| 103 | ZAK | 0.44725004 |
| 104 | KSR1 | 0.44191974 |
| 105 | PLK2 | 0.44012143 |
| 106 | PRKCZ | 0.43906417 |
| 107 | ERN1 | 0.43295996 |
| 108 | FGFR1 | 0.42504530 |
| 109 | PRKACA | 0.42124181 |
| 110 | PRKACB | 0.41722503 |
| 111 | SGK1 | 0.41603043 |
| 112 | WNK1 | 0.41534078 |
| 113 | NTRK1 | 0.41511226 |
| 114 | CDC42BPA | 0.41476834 |
| 115 | EPHB2 | 0.40242259 |
| 116 | NEK9 | 0.39489074 |
| 117 | MAP3K2 | 0.39438693 |
| 118 | FGFR2 | 0.39084327 |
| 119 | RPS6KA3 | 0.38315586 |
| 120 | JAK2 | 0.37605266 |
| 121 | ACVR1B | 0.36832382 |
| 122 | CSNK1G1 | 0.36022861 |
| 123 | FER | 0.36003047 |
| 124 | CASK | 0.35503044 |
| 125 | WEE1 | 0.35415723 |
| 126 | ARAF | 0.34879621 |
| 127 | MKNK2 | 0.33112634 |
| 128 | BCR | 0.31981005 |
| 129 | PRKDC | 0.31550572 |
| 130 | CSNK1E | 0.30171128 |
| 131 | STK4 | 0.28935448 |
| 132 | TLK1 | 0.28357905 |
| 133 | AKT3 | 0.27933423 |
| 134 | ADRBK2 | 0.27500755 |
| 135 | RPS6KB1 | 0.26172404 |
| 136 | NTRK2 | 0.25927975 |
| 137 | MAPK10 | 0.25723123 |
| 138 | PRKCG | 0.24333822 |
| 139 | NUAK1 | 0.23407548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.54588114 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.08405551 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.93185607 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.88205666 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.87155056 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.84755414 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.80931290 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70094418 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.62630121 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.54380616 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49314009 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.45316700 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22358951 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.20614116 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.12059104 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.10055870 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.98738022 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.91327401 |
| 19 | * Circadian rhythm_Homo sapiens_hsa04710 | 1.88743631 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.72690550 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69927824 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69089847 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67926769 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61032382 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57085046 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52362805 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49581144 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49298578 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.47967513 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38757630 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34938656 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29992028 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29828505 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27750435 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24989026 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.17009294 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11538172 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07730038 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07607783 |
| 40 | Tight junction_Homo sapiens_hsa04530 | 1.05218248 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05138596 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.04109564 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.03709000 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03399980 |
| 45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00493437 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.00147691 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97248872 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97012933 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95084699 |
| 50 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.94057602 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92247707 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91560271 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.89249728 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89059006 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88049756 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88031108 |
| 57 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86894310 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.86398672 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83912918 |
| 60 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.79683482 |
| 61 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.79523750 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78415607 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.76802465 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.76691709 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76430578 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.76189938 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75660317 |
| 68 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74656135 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73754067 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.73041807 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70569640 |
| 72 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.70231733 |
| 73 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69640939 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68235976 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.66216805 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63280700 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62162512 |
| 78 | * Insulin resistance_Homo sapiens_hsa04931 | 0.61938547 |
| 79 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61503611 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59988947 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59202666 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57541157 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57294717 |
| 84 | Morphine addiction_Homo sapiens_hsa05032 | 0.56396941 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56349915 |
| 86 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55418964 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.54700841 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49159286 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.49050616 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.48732558 |
| 91 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48547813 |
| 92 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48354446 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48234494 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46503385 |
| 95 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45325807 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43988804 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42364901 |
| 98 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41970939 |
| 99 | Melanogenesis_Homo sapiens_hsa04916 | 0.41734582 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41730106 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41129645 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40469014 |
| 103 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40299926 |
| 104 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40285454 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39980778 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39873593 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39012462 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38605648 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38135762 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37200674 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36855547 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.36806852 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34338335 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33104385 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32340375 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.29847657 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29614337 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29515450 |
| 119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.28443479 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27524995 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27311596 |
| 122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27168605 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24817762 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24648150 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23913531 |
| 126 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.21038940 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.19926746 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19403279 |
| 129 | GABAergic synapse_Homo sapiens_hsa04727 | 0.19136462 |
| 130 | Renin secretion_Homo sapiens_hsa04924 | 0.18858331 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.18772180 |
| 132 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.18754637 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18294783 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18015258 |

